BIOLASE, Inc. (BIOL) NASDAQ

0.02

+0.0043(+27.39%)

Updated at October 02, 2024 04:00PM

Currency In USD

Valuation

Market Cap1.43M
Enterprise Value12.78M
P/E Ratio-0.03
PEG Ratio-0
Price/Sales Ratio0.02
Price/Book Ratio-0.15
Enterprise/Revenue0.22
Enterprise/EBITDA-0.68

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterJune 30, 2024

Profitability

Profit Margin-0.42
Operating Margin-0.36

Management Effectiveness

Return On Assets-0.63
Return On Equity122.67

Income Statement

Revenue49.16M
Revenue/Share1.38
Gross Profit16.72M
EBITDA-15.14M
Net Income-20.63M
Diluted EPS-16.14

Balance Sheet

Total Cash5.27M
Total Cash/Share0.16
Total Debt14.64M
Total Debt/Equity-3.1
Current Ratio0.71
Book Value Per Share-0.13

Price History

52-Week Change-98.81
52-Week High1.94
52-Week Low0.02
Moving Average 50 Days0.06
Moving Average 200 Days0.28

Statistics

Average Volume201,374
Shares Outstanding36.6M
% Held by Institutions0.01

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:100
Last Split DateJuly 28, 2023